46,193 Shares in LifeStance Health Group, Inc. (NASDAQ:LFST) Acquired by AlphaQuest LLC

AlphaQuest LLC bought a new stake in shares of LifeStance Health Group, Inc. (NASDAQ:LFSTFree Report) in the fourth quarter, HoldingsChannel reports. The institutional investor bought 46,193 shares of the company’s stock, valued at approximately $340,000.

Other institutional investors have also added to or reduced their stakes in the company. Geode Capital Management LLC grew its position in shares of LifeStance Health Group by 26.8% during the 3rd quarter. Geode Capital Management LLC now owns 3,452,178 shares of the company’s stock valued at $24,170,000 after acquiring an additional 729,794 shares during the period. Charles Schwab Investment Management Inc. grew its holdings in LifeStance Health Group by 36.9% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,104,453 shares of the company’s stock valued at $7,731,000 after purchasing an additional 297,723 shares during the period. SG Americas Securities LLC grew its holdings in LifeStance Health Group by 65.7% during the fourth quarter. SG Americas Securities LLC now owns 90,355 shares of the company’s stock valued at $666,000 after purchasing an additional 35,823 shares during the period. JPMorgan Chase & Co. increased its position in LifeStance Health Group by 13.0% in the third quarter. JPMorgan Chase & Co. now owns 94,636 shares of the company’s stock worth $662,000 after buying an additional 10,894 shares in the last quarter. Finally, Point72 Asset Management L.P. raised its stake in shares of LifeStance Health Group by 24.9% in the third quarter. Point72 Asset Management L.P. now owns 1,100,441 shares of the company’s stock worth $7,703,000 after buying an additional 219,329 shares during the period. 85.50% of the stock is currently owned by institutional investors.

LifeStance Health Group Stock Down 1.0 %

Shares of LFST opened at $6.92 on Friday. LifeStance Health Group, Inc. has a 12-month low of $4.64 and a 12-month high of $8.61. The company has a current ratio of 1.32, a quick ratio of 1.32 and a debt-to-equity ratio of 0.19. The company has a market capitalization of $2.66 billion, a PE ratio of -26.62 and a beta of 1.27. The business’s 50 day moving average is $7.80 and its 200 day moving average is $7.33.

Wall Street Analysts Forecast Growth

LFST has been the subject of several analyst reports. William Blair reissued an “outperform” rating on shares of LifeStance Health Group in a report on Friday, February 28th. The Goldman Sachs Group upgraded shares of LifeStance Health Group from a “neutral” rating to a “buy” rating and set a $10.00 price objective on the stock in a research report on Monday, December 16th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and three have assigned a buy rating to the company’s stock. According to MarketBeat.com, LifeStance Health Group presently has an average rating of “Hold” and an average price target of $8.63.

Read Our Latest Report on LifeStance Health Group

LifeStance Health Group Profile

(Free Report)

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.

Read More

Want to see what other hedge funds are holding LFST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LifeStance Health Group, Inc. (NASDAQ:LFSTFree Report).

Institutional Ownership by Quarter for LifeStance Health Group (NASDAQ:LFST)

Receive News & Ratings for LifeStance Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeStance Health Group and related companies with MarketBeat.com's FREE daily email newsletter.